Funder: National Institutes of Health (NIH)

Due Dates: November 17, 2025 (SBIR Phase II & Fast-Track applications)

Funding Amounts: Supports SBIR Phase II and Fast-Track awards; budget and duration depend on project needs, but NIH SBIR standard limits apply unless a waiver is granted.

Summary: Supports small businesses in conducting exploratory clinical trials focused on products relevant to the mission and goals of the National Institute of Neurological Disorders and Stroke (NINDS).

Key Information: Only SBIR Phase II and Fast-Track applications are supported; Phase I only accepted as part of Fast-Track.